Page last updated: 2024-09-03

3-amino-2-hydroxy-4-phenylbutanoic acid and thiazoles

3-amino-2-hydroxy-4-phenylbutanoic acid has been researched along with thiazoles in 6 studies

Compound Research Comparison

Studies
(3-amino-2-hydroxy-4-phenylbutanoic acid)
Trials
(3-amino-2-hydroxy-4-phenylbutanoic acid)
Recent Studies (post-2010)
(3-amino-2-hydroxy-4-phenylbutanoic acid)
Studies
(thiazoles)
Trials
(thiazoles)
Recent Studies (post-2010) (thiazoles)
420333,1792,10012,330

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukazawa, T; Hayashi, H; Kato, R; Kiso, Y; Mimoto, T; Misawa, S; Nojima, S; Sato, H; Shintani, M; Takaku, H; Terashima, K; Ueno, T1
Elder, JH; Le, VD; Lin, YC; Mak, CC; Wong, CH1
Freire, E; Kimura, T; Kiso, Y; Luque, I; Nezami, A1
Ami, E; Hamada, Y; Hayashi, Y; Hidaka, K; Kimura, T; Kiso, Y; Nakahara, K; Nakatani, S; Nguyen, JT; Sato, A1
Ami, E; Hamada, Y; Hayashi, Y; Hidaka, K; Hori, Y; Kimura, T; Kiso, Y; Nagai, A; Nakahara, K; Nakatani, S; Nguyen, JT; Ohnishi, N; Sato, A1
Freire, E; Hidaka, K; Hori, Y; Kashimoto, K; Kawasaki, Y; Kimura, T; Kiso, Y; Miura, T; Ruben, AJ; Uemura, T1

Other Studies

6 other study(ies) available for 3-amino-2-hydroxy-4-phenylbutanoic acid and thiazoles

ArticleYear
Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine.
    Journal of medicinal chemistry, 1999, May-20, Volume: 42, Issue:10

    Topics: Administration, Oral; Animals; Biological Availability; Cell Line; Dipeptides; Dogs; Drug Evaluation, Preclinical; HIV Protease Inhibitors; HIV-1; Inhibitory Concentration 50; Injections, Intravenous; Oligopeptides; Phenylbutyrates; Rats; Structure-Activity Relationship; Thiazoles; Thiazolidines

1999
Structure-activity studies of FIV and HIV protease inhibitors containing allophenylnorstatine.
    Bioorganic & medicinal chemistry, 2001, Volume: 9, Issue:5

    Topics: Aspartic Acid Endopeptidases; Drug Resistance; HIV Protease; HIV Protease Inhibitors; Inhibitory Concentration 50; Mutagenesis; Oligonucleotides; Phenylbutyrates; Protease Inhibitors; Structure-Activity Relationship; Thiazoles

2001
Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target.
    Biochemistry, 2002, Feb-19, Volume: 41, Issue:7

    Topics: Amides; Animals; Antimalarials; Aspartic Acid Endopeptidases; Binding Sites; Chromogenic Compounds; Enzyme Stability; Erythrocytes; Humans; Models, Molecular; Phenylbutyrates; Plasmodium falciparum; Protease Inhibitors; Protozoan Proteins; Substrate Specificity; Thermodynamics; Thiazoles

2002
Synthesis and antiviral property of allophenylnorstatine-based HIV protease inhibitors incorporating D-cysteine derivatives as P2/P3 moieties.
    Bioorganic & medicinal chemistry letters, 2007, Aug-01, Volume: 17, Issue:15

    Topics: Amides; Cell Line; Cysteine; HIV; HIV Protease Inhibitors; Humans; Models, Molecular; Phenylbutyrates; Thiazoles

2007
Combination of non-natural D-amino acid derivatives and allophenylnorstatine-dimethylthioproline scaffold in HIV protease inhibitors have high efficacy in mutant HIV.
    Journal of medicinal chemistry, 2008, May-22, Volume: 51, Issue:10

    Topics: Amino Acids; Drug Resistance, Viral; HIV Protease; HIV Protease Inhibitors; HIV-1; Models, Molecular; Mutation; Phenylbutyrates; Stereoisomerism; Structure-Activity Relationship; Thiazoles

2008
Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitution.
    Bioorganic & medicinal chemistry letters, 2010, Aug-15, Volume: 20, Issue:16

    Topics: Antimalarials; Aspartic Acid Endopeptidases; Binding Sites; Computer Simulation; Ethylenediamines; Phenylbutyrates; Protease Inhibitors; Protozoan Proteins; Structure-Activity Relationship; Thiazoles

2010